---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-037562"
form_type: "8-K"
ticker: "USAQ"
cik: "0000856984"
company_name: "QHSLab, Inc."
filed_at: "2023-10-18T23:59:59+00:00"
generated_at: "2026-06-09T22:15:23.813826+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "medium"
source: SEC EDGAR
---

# QHSLab reports 30K+ digital assessments YTD, over $1M revenue for 9 months

## Summary
- Over 30,000 patient digital medicine assessments in first 9 months of 2023; 800 initiated allergen immunotherapy.
- Unaudited revenue for nine months ended Sep 30, 2023 exceeded $1 million with growing gross margins.
- Physician client reimbursements increased 20-30% from adopting QHSLab digital health services.
- ISP service line forecast to double daily output by year-end 2023; 2024 assessment run rate expected >65,000.
- Platform added multi-language support, EHR matching, and automated patient self-management tools.

## SEC filing metadata
- accession: 0001493152-23-037562
- form_type: 8-K
- ticker: USAQ
- cik: 0000856984
- company_name: QHSLab, Inc.
- filed_at: 2023-10-18T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: medium
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/856984/000149315223037562/0001493152-23-037562-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/856984/000149315223037562/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-037562
- JSON: https://secwatch.observer/filing/0001493152-23-037562.json
- Plain text: https://secwatch.observer/filing/0001493152-23-037562.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.